Topics

Gliomas | Etiopathogenesis | IDH mutations

Home > Publications > Topics > Gliomas > Etiopathogenesis > IDH mutations

Kitagawa Y, Kobayashi A, Cahill DP, Wakimoto H, Tanaka S.
Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors.
Biochim Biophys Acta Rev Cancer. 2024 Apr 21;1879(3):189102. doi: 10.1016/j.bbcan.2024.189102. PMID: 38653436. Review˰ ˍ

Choate KA, Pratt EPS, Jennings MJ, Winn RJ, Mann PB.
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications.
Biology (Basel). 2024 Oct 30;13(11):885. doi: 10.3390/biology13110885. PMID: 39596840. Review. ˍ

Jiang H, Wang X, Chen X, Zhang S, Ren Q, Li M, Li M, Ren X, Lin S, Cui Y.
Unraveling the heterogeneity of WHO grade 4 gliomas: insights from clinical, imaging, and molecular characterization.
Discov Oncol. 2025 Feb 3;16(1):111. doi: 10.1007/s12672-025-01811-0. PMID: 39899184. Observational study. ˍ